Listed

Pacira BioSciences, Inc.

PCRXNasdaqCIK 1396814HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$192.4m, Q2 FY2026
Operating income$4.3m, Q2 FY2026
Net income$4.7m, Q2 FY2026
Pacira BioSciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m164Revenue, Q3 FY2023, three months to 2023-09-30$163.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure181Revenue, Q4 FY2023, three months to 2023-12-31$181.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure167Revenue, Q1 FY2024, three months to 2024-03-31$167.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure178Revenue, Q2 FY2024, three months to 2024-06-30$178.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure169Revenue, Q3 FY2024, three months to 2024-09-30$168.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure187Revenue, Q4 FY2024, three months to 2024-12-31$187.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure169Revenue, Q1 FY2025, three months to 2025-03-31$168.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure181Revenue, Q2 FY2025, three months to 2025-06-30$181.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure180Revenue, Q3 FY2025, three months to 2025-09-30$179.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure197Revenue, Q4 FY2025, three months to 2025-12-31$196.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure177Revenue, Q1 FY2026, three months to 2026-03-31$177.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure192Revenue, Q2 FY2026, three months to 2026-06-30$192.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Cost of revenue$m39.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$39.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure47.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$47.7m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure47.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$47.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure44.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$44.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure38.9Cost of revenue, Q3 FY2024, three months to 2024-09-30$38.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure39.9Cost of revenue, Q4 FY2024, three months to 2024-12-31$39.9m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure34.3Cost of revenue, Q1 FY2025, three months to 2025-03-31$34.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure40.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$40.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure34.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$34.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure40.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$40.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure36.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$36.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure44.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$44.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Research and development$m20.8Research and development, Q3 FY2023, three months to 2023-09-30$20.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure19.5Research and development, Q4 FY2023, three months to 2023-12-31$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure18.2Research and development, Q1 FY2024, three months to 2024-03-31$18.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure20.3Research and development, Q2 FY2024, three months to 2024-06-30$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure19.1Research and development, Q3 FY2024, three months to 2024-09-30$19.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure23.9Research and development, Q4 FY2024, three months to 2024-12-31$23.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure25.3Research and development, Q1 FY2025, three months to 2025-03-31$25.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure28.2Research and development, Q2 FY2025, three months to 2025-06-30$28.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure26.0Research and development, Q3 FY2025, three months to 2025-09-30$26.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure37.5Research and development, Q4 FY2025, three months to 2025-12-31$37.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure28.1Research and development, Q1 FY2026, three months to 2026-03-31$28.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure30.2Research and development, Q2 FY2026, three months to 2026-06-30$30.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Selling, general and administrative$m67.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$67.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure65.8Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$65.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure72.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$72.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure68.1Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$68.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure74.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$74.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure79.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$79.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure86.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$86.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure88.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$88.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure91.8Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$91.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure102Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$101.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure93.9Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$93.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure91.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$91.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Operating income$m17.7Operating income, Q3 FY2023, three months to 2023-09-30$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure33.2Operating income, Q4 FY2023, three months to 2023-12-31$33.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure13.2Operating income, Q1 FY2024, three months to 2024-03-31$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure28.2Operating income, Q2 FY2024, three months to 2024-06-30$28.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure(140)Operating income, Q3 FY2024, three months to 2024-09-30−$139.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure24.7Operating income, Q4 FY2024, three months to 2024-12-31$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure2.0Operating income, Q1 FY2025, three months to 2025-03-31$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure8.5Operating income, Q2 FY2025, three months to 2025-06-30$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure6.4Operating income, Q3 FY2025, three months to 2025-09-30$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure2.3Operating income, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure6.9Operating income, Q1 FY2026, three months to 2026-03-31$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure4.3Operating income, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Interest expense$m3.5Interest expense, Q3 FY2023, three months to 2023-09-30$3.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure3.4Interest expense, Q4 FY2023, three months to 2023-12-31$3.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-29, accession 0001396814-24-000030. Derived: 12-month figure less the 9-month figure.Report this figure3.3Interest expense, Q1 FY2024, three months to 2024-03-31$3.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure3.9Interest expense, Q2 FY2024, three months to 2024-06-30$3.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure4.7Interest expense, Q3 FY2024, three months to 2024-09-30$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure4.7Interest expense, Q4 FY2024, three months to 2024-12-31$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure4.6Interest expense, Q1 FY2025, three months to 2025-03-31$4.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure4.7Interest expense, Q2 FY2025, three months to 2025-06-30$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure4.3Interest expense, Q3 FY2025, three months to 2025-09-30$4.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure3.9Interest expense, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure3.7Interest expense, Q1 FY2026, three months to 2026-03-31$3.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure3.6Interest expense, Q2 FY2026, three months to 2026-06-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Income tax$m5.7Income tax, Q3 FY2023, three months to 2023-09-30$5.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure8.9Income tax, Q4 FY2023, three months to 2023-12-31$8.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure4.7Income tax, Q1 FY2024, three months to 2024-03-31$4.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure17.7Income tax, Q2 FY2024, three months to 2024-06-30$17.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure4.6Income tax, Q3 FY2024, three months to 2024-09-30$4.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure9.5Income tax, Q4 FY2024, three months to 2024-12-31$9.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure3.9Income tax, Q1 FY2025, three months to 2025-03-31$3.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure2.9Income tax, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure4.1Income tax, Q3 FY2025, three months to 2025-09-30$4.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure(1.1)Income tax, Q4 FY2025, three months to 2025-12-31−$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure2.1Income tax, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure(2.1)Income tax, Q2 FY2026, three months to 2026-06-30−$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Net income$m10.9Net income, Q3 FY2023, three months to 2023-09-30$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure24.9Net income, Q4 FY2023, three months to 2023-12-31$24.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure9.0Net income, Q1 FY2024, three months to 2024-03-31$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure18.9Net income, Q2 FY2024, three months to 2024-06-30$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure(143)Net income, Q3 FY2024, three months to 2024-09-30−$143.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure16.0Net income, Q4 FY2024, three months to 2024-12-31$16.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure4.8Net income, Q1 FY2025, three months to 2025-03-31$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure(4.8)Net income, Q2 FY2025, three months to 2025-06-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure5.4Net income, Q3 FY2025, three months to 2025-09-30$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure1.6Net income, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure2.9Net income, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure4.7Net income, Q2 FY2026, three months to 2026-06-30$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Diluted EPS$ per share0.23Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figurenot reported0.19Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure0.39Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure(3.11)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figurenot reported0.10Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure(0.11)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure0.12Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figurenot reported0.07Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure0.12Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Basic EPS$ per share0.23Basic EPS, Q3 FY2023, three months to 2023-09-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figurenot reported0.19Basic EPS, Q1 FY2024, three months to 2024-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure0.41Basic EPS, Q2 FY2024, three months to 2024-06-30$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure(3.11)Basic EPS, Q3 FY2024, three months to 2024-09-30−$3.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figurenot reported0.10Basic EPS, Q1 FY2025, three months to 2025-03-31$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure(0.11)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure0.12Basic EPS, Q3 FY2025, three months to 2025-09-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figurenot reported0.07Basic EPS, Q1 FY2026, three months to 2026-03-31$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure0.12Basic EPS, Q2 FY2026, three months to 2026-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure

Balance sheet

Cash and equivalents$205.9m, Q2 FY2026
Long-term debt$363.1m, Q2 FY2026
Shareholders' equity$672.0m, Q2 FY2026
Pacira BioSciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m99.1Cash and equivalents, Q3 FY2023, at 2023-09-30$99.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure153Cash and equivalents, FY2023, at 2023-12-31$153.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0001396814-25-000041.Report this figure184Cash and equivalents, Q1 FY2024, at 2024-03-31$184.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure247Cash and equivalents, Q2 FY2024, at 2024-06-30$247.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-30, accession 0001396814-24-000098.Report this figure246Cash and equivalents, Q3 FY2024, at 2024-09-30$246.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure277Cash and equivalents, FY2024, at 2024-12-31$276.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure284Cash and equivalents, Q1 FY2025, at 2025-03-31$283.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure300Cash and equivalents, Q2 FY2025, at 2025-06-30$300.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure148Cash and equivalents, Q3 FY2025, at 2025-09-30$147.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure159Cash and equivalents, FY2025, at 2025-12-31$158.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure144Cash and equivalents, Q1 FY2026, at 2026-03-31$144.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure206Cash and equivalents, Q2 FY2026, at 2026-06-30$205.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Current assets$m447Current assets, Q3 FY2023, at 2023-09-30$447.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure510Current assets, FY2023, at 2023-12-31$510.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001396814-25-000041.Report this figure543Current assets, Q1 FY2024, at 2024-03-31$543.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure632Current assets, Q2 FY2024, at 2024-06-30$632.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-30, accession 0001396814-24-000098.Report this figure690Current assets, Q3 FY2024, at 2024-09-30$690.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure745Current assets, FY2024, at 2024-12-31$745.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure760Current assets, Q1 FY2025, at 2025-03-31$760.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure746Current assets, Q2 FY2025, at 2025-06-30$745.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure563Current assets, Q3 FY2025, at 2025-09-30$562.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure548Current assets, FY2025, at 2025-12-31$548.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure515Current assets, Q1 FY2026, at 2026-03-31$515.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure615Current assets, Q2 FY2026, at 2026-06-30$615.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Total assets$m1,534Total assets, Q3 FY2023, at 2023-09-30$1.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure1,574Total assets, FY2023, at 2023-12-31$1.57bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001396814-25-000041.Report this figure1,583Total assets, Q1 FY2024, at 2024-03-31$1.58bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure1,647Total assets, Q2 FY2024, at 2024-06-30$1.65bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-30, accession 0001396814-24-000098.Report this figure1,522Total assets, Q3 FY2024, at 2024-09-30$1.52bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure1,554Total assets, FY2024, at 2024-12-31$1.55bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure1,587Total assets, Q1 FY2025, at 2025-03-31$1.59bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure1,537Total assets, Q2 FY2025, at 2025-06-30$1.54bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure1,298Total assets, Q3 FY2025, at 2025-09-30$1.30bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure1,265Total assets, FY2025, at 2025-12-31$1.26bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure1,209Total assets, Q1 FY2026, at 2026-03-31$1.21bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure1,244Total assets, Q2 FY2026, at 2026-06-30$1.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Current liabilities$m93.7Current liabilities, Q3 FY2023, at 2023-09-30$93.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure97.4Current liabilities, FY2023, at 2023-12-31$97.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001396814-25-000041.Report this figure93.4Current liabilities, Q1 FY2024, at 2024-03-31$93.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure92.7Current liabilities, Q2 FY2024, at 2024-06-30$92.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-30, accession 0001396814-24-000098.Report this figure306Current liabilities, Q3 FY2024, at 2024-09-30$306.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure310Current liabilities, FY2024, at 2024-12-31$309.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure315Current liabilities, Q1 FY2025, at 2025-03-31$314.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure313Current liabilities, Q2 FY2025, at 2025-06-30$313.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure107Current liabilities, Q3 FY2025, at 2025-09-30$107.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure121Current liabilities, FY2025, at 2025-12-31$120.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure109Current liabilities, Q1 FY2026, at 2026-03-31$108.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure122Current liabilities, Q2 FY2026, at 2026-06-30$122.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Total liabilities$m703Total liabilities, Q3 FY2023, at 2023-09-30$702.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure704Total liabilities, FY2023, at 2023-12-31$704.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001396814-25-000041.Report this figure691Total liabilities, Q1 FY2024, at 2024-03-31$691.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure768Total liabilities, Q2 FY2024, at 2024-06-30$767.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-30, accession 0001396814-24-000098.Report this figure772Total liabilities, Q3 FY2024, at 2024-09-30$772.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure775Total liabilities, FY2024, at 2024-12-31$775.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure788Total liabilities, Q1 FY2025, at 2025-03-31$788.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure779Total liabilities, Q2 FY2025, at 2025-06-30$779.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure570Total liabilities, Q3 FY2025, at 2025-09-30$570.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure572Total liabilities, FY2025, at 2025-12-31$571.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure555Total liabilities, Q1 FY2026, at 2026-03-31$554.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure572Total liabilities, Q2 FY2026, at 2026-06-30$572.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Long-term debt$mnot reported522Long-term debt, FY2023, at 2023-12-31$522.4m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-27, accession 0001396814-25-000041.Report this figurenot reportednot reportednot reported384Long-term debt, FY2024, at 2024-12-31$383.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure583Long-term debt, Q1 FY2025, at 2025-03-31$583.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure580Long-term debt, Q2 FY2025, at 2025-06-30$580.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure377Long-term debt, Q3 FY2025, at 2025-09-30$376.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure372Long-term debt, FY2025, at 2025-12-31$372.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure368Long-term debt, Q1 FY2026, at 2026-03-31$367.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure363Long-term debt, Q2 FY2026, at 2026-06-30$363.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported202Current portion of debt, FY2024, at 2024-12-31$201.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figurenot reportednot reported0.0Current portion of debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figurenot reportednot reported
Shareholders' equity$m832Shareholders' equity, Q3 FY2023, at 2023-09-30$831.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure870Shareholders' equity, FY2023, at 2023-12-31$870.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001628280-26-012297.Report this figure892Shareholders' equity, Q1 FY2024, at 2024-03-31$892.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure879Shareholders' equity, Q2 FY2024, at 2024-06-30$879.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure750Shareholders' equity, Q3 FY2024, at 2024-09-30$749.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure778Shareholders' equity, FY2024, at 2024-12-31$778.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure799Shareholders' equity, Q1 FY2025, at 2025-03-31$798.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure758Shareholders' equity, Q2 FY2025, at 2025-06-30$757.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure727Shareholders' equity, Q3 FY2025, at 2025-09-30$727.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure693Shareholders' equity, FY2025, at 2025-12-31$693.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure654Shareholders' equity, Q1 FY2026, at 2026-03-31$653.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure672Shareholders' equity, Q2 FY2026, at 2026-06-30$672.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure

Cash flow

Operating cash flow$57.5m, Q2 FY2026
Capital expenditure$1.3m, Q2 FY2026
Share repurchases$0, Q2 FY2026
Pacira BioSciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m44.4Operating cash flow, Q3 FY2023, three months to 2023-09-30$44.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001396814-24-000141. Derived: 9-month figure less the 6-month figure.Report this figure47.6Operating cash flow, Q4 FY2023, three months to 2023-12-31$47.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure49.1Operating cash flow, Q1 FY2024, three months to 2024-03-31$49.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure53.2Operating cash flow, Q2 FY2024, three months to 2024-06-30$53.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001396814-25-000102. Derived: 6-month figure less the 3-month figure.Report this figure53.9Operating cash flow, Q3 FY2024, three months to 2024-09-30$53.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001628280-25-050176. Derived: 9-month figure less the 6-month figure.Report this figure33.1Operating cash flow, Q4 FY2024, three months to 2024-12-31$33.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure35.5Operating cash flow, Q1 FY2025, three months to 2025-03-31$35.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure12.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001628280-26-052635. Derived: 6-month figure less the 3-month figure.Report this figure60.8Operating cash flow, Q3 FY2025, three months to 2025-09-30$60.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001628280-25-050176. Derived: 9-month figure less the 6-month figure.Report this figure43.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$43.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure25.7Operating cash flow, Q1 FY2026, three months to 2026-03-31$25.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure57.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$57.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001628280-26-052635. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m3.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001396814-24-000141. Derived: 9-month figure less the 6-month figure.Report this figure1.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure2.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure1.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001396814-25-000102. Derived: 6-month figure less the 3-month figure.Report this figure4.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-050176. Derived: 9-month figure less the 6-month figure.Report this figure2.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure8.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$8.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure2.7Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001628280-26-052635. Derived: 6-month figure less the 3-month figure.Report this figure3.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-050176. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$218.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure2.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure1.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001628280-26-052635. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-06, accession 0001396814-24-000141. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001628280-25-050176. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure50.0Share repurchases, Q2 FY2025, three months to 2025-06-30$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0001628280-26-052635. Derived: 6-month figure less the 3-month figure.Report this figure50.0Share repurchases, Q3 FY2025, three months to 2025-09-30$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001628280-25-050176. Derived: 9-month figure less the 6-month figure.Report this figure48.2Share repurchases, Q4 FY2025, three months to 2025-12-31$48.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-26, accession 0001628280-26-012297. Derived: 12-month figure less the 9-month figure.Report this figure50.0Share repurchases, Q1 FY2026, three months to 2026-03-31$50.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0001628280-26-052635. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)40.30m, Q2 FY2026
Pacira BioSciences, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares45.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3045,831,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001396814-23-000079.Report this figure45.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3145,949,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001396814-24-000045.Report this figure52.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3052,054,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-30, accession 0001396814-24-000098.Report this figure52.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3052,067,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001396814-24-000141.Report this figure52.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3152,193,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001396814-25-000061.Report this figure50.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3050,539,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001396814-25-000102.Report this figure46.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3046,134,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure46.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3146,526,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure45.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3045,459,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure44.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3044,459,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001628280-25-050176.Report this figure40.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3140,910,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001628280-26-028871.Report this figure40.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3040,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure

Shares outstanding: 39.86mShares outstanding, period not labelled, at 2026-08-0339,861,886 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001628280-26-052635.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.